Global health insurance service company
Monitor pharmacy issues related to H.R 6395 / S. 4049, the National Defense Authorization Act for Fiscal Year 2021. Monitor issues related to H.R. 861, the End Surprise Billing Act; H.R. 3502, the Protecting People from Surprise Medical Bills Act; H.R. 2328, the Community Health Investment, Modernization, and Excellence Act of 2019; H.R. 3630, the No Surprises Act; and H.R. 5800, the Ban Surprise Billing Act; issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Families First Coronavirus Response Act; P.L. 116-136, the Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to S. 1895, the Lower Health Care Costs Act, including: surprise billing and transparency and information sharing in the individual and commercial markets; issues related to H.R. 6644 / S. 3741, to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage for services furnished via telehealth if such services would be covered if furnished in-person during the COVID-19 emergency; issues related to H.R. 7839 Continuing Access to In Home Intravenous Immunoglobulin (IVIG) Act; issues related to H.R. 133 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act. Monitor H.R. 7659 / S. 4840, the Ensuring Parity in MA for Audio-Only Telehealth Act of 2020, to amend title XVIII of the Social Security Act to require the inclusion of certain audio-only diagnoses in the determination of risk adjustment for Medicare Advantage plans, and for other purposes; issues related to prior authorization and utilization management, H.R. 3107, the Improving Seniors' Timely Access to Care Act of 2019; issues related to Pharmacy Direct and Indirect Remuneration (DIR); H.R. 1034, the Phair Pricing Act of 2019; S.640, the Phair Pricing Act of 2019; H.R. 803, the Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 1035, the Improving Transparency and Accuracy in Medicare Part D Spending Act; proposals that impact Medicare Part D such as formulary requirements, pharmacy benefit manager (PBM) disclosure provisions, closing the Part D coverage gap and direct negotiation of prescription drug prices; issues related to H.R. 133 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act.
DEF - Defense HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
INVARIANT LLC
740 15th St NW, Floor 5, Washington, DC, 20005, US
BENJAMIN KLEIN LINDLEY SHERER BENJAMIN KLEIN KATHRYN WISE BENJAMIN KLEIN KATHRYN WISE